title: Efficacy and safety of tumor necrosis factor inhibitors in acute generalized pustular psoriasis.
authors.forename: Manuelle
authors.initials: M
authors.lastname: Viguier
authors.forename: François
authors.initials: F
authors.lastname: Aubin
authors.forename: Emmanuel
authors.initials: E
authors.lastname: Delaporte
authors.forename: Cécile
authors.initials: C
authors.lastname: Pagès
authors.forename: Carle
authors.initials: C
authors.lastname: Paul
authors.forename: Marie
authors.initials: M
authors.lastname: Beylot-Barry
authors.forename: Catherine
authors.initials: C
authors.lastname: Goujon
authors.forename: Michel
authors.initials: M
authors.lastname: Rybojad
authors.forename: Hervé
authors.initials: H
authors.lastname: Bachelez
mesh_terms: D000208:Acute Disease; D000068879:Adalimumab; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000009:adverse effects / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized / Q000009:adverse effects / Q000627:therapeutic use*; D000068800:Etanercept; D005260:Female; D006801:Humans; D007074:Immunoglobulin G / Q000009:adverse effects / Q000627:therapeutic use*; D000069285:Infliximab; D008297:Male; D011565:Psoriasis / Q000188:drug therapy* / Q000473:pathology; D018124:Receptors, Tumor Necrosis Factor / Q000627:therapeutic use*; D012189:Retrospective Studies; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D007074:Immunoglobulin G; D018124:Receptors, Tumor Necrosis Factor; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab; D000068879:Adalimumab; D000068800:Etanercept